日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

P862: A PHASE 1 FIRST-IN-HUMAN MONOTHERAPY STUDY OF ABBV-383, A BCMA × CD3 BISPECIFIC T-CELL–REDIRECTING ANTIBODY, IN RELAPSED/REFRACTORY MULTIPLE MYELOMA

P862：ABBV-383（一种BCMA×CD3双特异性T细胞定向抗体）治疗复发/难治性多发性骨髓瘤的I期首次人体单药治疗研究

期刊:
影响因子:
doi:10.1002/oby.23854
Höchsmann, Christoph; Martin, Corby K; Apolzan, John W; Dorling, James L; Newton, Robert L Jr; Denstel, Kara D; Mire, Emily F; Johnson, William D; Zhang, Dachuan; Arnold, Connie L; Davis, Terry C; Fonseca, Vivian; Thethi, Tina K; Lavie, Carl J; Springgate, Benjamin; Katzmarzyk, Peter T; Weisel, Katja; D’souza, Anita; Hurd, David; Voorhees, Peter; Teipel, Raphael; Chung, Alfred; Rodriguez, Cesar; Tuchman, Sacha; Korde, Neha; Safah, Hana; Bueno, Orlando; Feng, Zhongling; Rosenberg, Tanya; Kumar Pothacamury, Rajvineeth; Ross, Jeremy; Lee, Shane; Jin, Ziyi; Talati, Chetasi; Kumar, Shaji; Vij, Ravi
T细胞
多发性骨髓瘤
CD3
T细胞
骨髓瘤
细胞生物学
免疫/内分泌
发表日期：2023
文献求助 收藏

A Phase I First-in-Human Study of ABBV-383, a B-Cell Maturation Antigen × CD3 Bispecific T-Cell Redirecting Antibody, in Patients With Relapsed/Refractory Multiple Myeloma

ABBV-383（一种B细胞成熟抗原×CD3双特异性T细胞重定向抗体）在复发/难治性多发性骨髓瘤患者中的I期首次人体研究

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.22.01504
D'Souza, Anita; Shah, Nina; Rodriguez, Cesar; Voorhees, Peter M; Weisel, Katja; Bueno, Orlando F; Pothacamury, Rajvineeth K; Freise, Kevin J; Yue, Susan; Ross, Jeremy A; Polepally, Akshanth R; Talati, Chetasi; Lee, Shane; Jin, Ziyi; Buelow, Ben; Vij, Ravi; Kumar, Shaji
B细胞
T细胞
多发性骨髓瘤
CD3
T细胞
Human
骨髓瘤
细胞生物学
免疫/内分泌
发表日期：2022
文献求助 收藏

Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients

伴有环状铁粒幼细胞和血小板增多的骨髓增生异常/骨髓增殖性肿瘤（MDS/MPN-RS-T）：Mayo-Moffitt 合作研究纳入 158 例患者

期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-022-00622-8
Mangaonkar, Abhishek A; Lasho, Terra L; Ketterling, Rhett P; Reichard, Kaaren K; Gangat, Naseema; Al-Kali, Aref; Begna, Kebede H; Pardanani, Animesh; Al Ali, Najla H; Talati, Chetasi; Sallman, David; Padron, Eric; Patnaik, Mrinal M; Tefferi, Ayalew; Komrokji, Rami
血小板
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

SF3B1-mutant myelodysplastic syndrome/myeloproliferative neoplasms: a unique molecular and prognostic entity

SF3B1突变型骨髓增生异常综合征/骨髓增殖性肿瘤：一种独特的分子和预后实体

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2021.280463
Mangaonkar, Abhishek A; Lasho, Terra L; Finke, Christy; Ketterling, Rhett P; Reichard, Kaaren K; McCullough, Kristen; Gangat, Naseema; Al-Kali, Aref; Begna, Kebede H; Hogan, William H; Litzow, Mark R; Alkhateeb, Hassan; Shah, Mithun; Pardanani, Animesh; Tefferi, Ayalew; Al Ali, Najla H; Talati, Chetasi; Sallman, David; Padron, Eric; Komrokji, Rami; Patnaik, Mrinal M
肿瘤
肿瘤免疫
SF3B1
发表日期：2022
文献求助 收藏

Molecular characteristics and outcomes in Hispanic and non-Hispanic patients with acute myeloid leukemia

西班牙裔和非西班牙裔急性髓系白血病患者的分子特征和预后

期刊:eJHaem
影响因子:1.2
doi:10.1002/jha2.589
Bradley, Terrence; Kwon, Deukwoo; Monge, Jorge; Sekeres, Mikkael; Chandhok, Namrata; Thomassen, Amber; Swords, Ronan; Padron, Eric; Lancet, Jeff; Talati, Chetasi; Watts, Justin
白血病
发表日期：2022
文献求助 收藏

MYC overexpression is associated with an early disease progression from MDS to AML

MYC 过表达与 MDS 向 AML 的早期疾病进展相关。

期刊:Leukemia Research
影响因子:2.2
doi:10.1016/j.leukres.2021.106733
Gajzer, David; Logothetis, Constantine N; Sallman, David A; Calon, Gregoire; Babu, Abida; Chan, Onyee; Vincelette, Nicole D; Volpe, Virginia O; Al Ali, Najla H; Basra, Pukhraz; Talati, Chetasi; Kuykendall, Andrew T; Mo, Qianxing; Padron, Eric; Sweet, Kendra; Komrokji, Rami S; Lancet, Jeffrey E; Yun, Seongseok; Zhang, Ling
MYC
发表日期：2021
文献求助 收藏

Comparisons of commonly used front-line regimens on survival outcomes in patients aged 70 years and older with acute myeloid leukemia

比较常用的一线治疗方案对70岁及以上急性髓系白血病患者生存结局的影响

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2018.208637
Talati, Chetasi; Dhulipala, Varun C; Extermann, Mar Tine; Ali, Najla Al; Kim, Jongphil; Komrokji, Rami; Sweet, Kendra; Kuykendall, Andrew; Sehovic, Marina; Reljic, Tea; Djulbegovic, Benjamin; Lancet, Jeffrey E
白血病
发表日期：2020
文献求助 收藏

Side-effects profile and outcomes of ponatinib in the treatment of chronic myeloid leukemia

帕纳替尼治疗慢性粒细胞白血病的副作用特征和疗效

期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2019000268
Chan, Onyee; Talati, Chetasi; Isenalumhe, Leidy; Shams, Samantha; Nodzon, Lisa; Fradley, Michael; Sweet, Kendra; Pinilla-Ibarz, Javier
细胞生物学
白血病
粒细胞
发表日期：2020
文献求助 收藏

Towards better combination regimens of cytarabine and FLT3 inhibitors in acute myeloid leukemia

探索阿糖胞苷和FLT3抑制剂在急性髓系白血病治疗中的更佳联合治疗方案

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-020-04114-z
Elmeliegy, Mohamed; Den Haese, Jason; Talati, Chetasi; Wetzler, Meir; Jusko, William J
白血病
FLT3
发表日期：2020
文献求助 收藏

Comparison of induction strategies and responses for acute myeloid leukemia patients after resistance to hypomethylating agents for antecedent myeloid malignancy

对既往髓系恶性肿瘤患者使用去甲基化药物治疗后出现耐药性的急性髓系白血病患者的诱导治疗策略和疗效比较

期刊:Leukemia Research
影响因子:2.2
doi:10.1016/j.leukres.2020.106367
Talati, Chetasi; Goldberg, Aaron D; Przespolewski, Amanda; Chan, Onyee; Ali, Najla Al; Kim, Jongphil; Famulare, Chris; Sallman, David; Padron, Eric; Kuykendall, Andrew; Lancet, Jeffrey E; Wang, Eunice; Tallman, Martin S; Komrokji, Rami; Sweet, Kendra
白血病
肿瘤
表观遗传
肿瘤免疫
发表日期：2020
文献求助 收藏